Projects Archive - Page 219 sur 249

DYAMTWVR* – SIL Dupilumab signature peptide qualifier

DYAMTWVR* – SIL Dupilumab signature peptide qualifier DYAMTWVR Stable Isotope Labeled Infliximab (DPL) peptide serves as a secondary internal standard to confirm DPL’s presence in biological samples by mass spectrometry. SB-PEPTIDE’s Dupilumab SIL signature...

LSITIRPR* – SIL Dupilumab signature peptide quantifier

LSITIRPR* – SIL Dupilumab signature peptide quantifier LSITIRPR Stable Isotope Labeled Infliximab (DPL) peptide serves as an internal standard to confirm DPL’s primary sequence by mass spectrometry. This allows expected sequences to be confirmed and...

ASQSIGTNIHWYQQR* – SIL Cetuximab signature peptide qualifier

ASQSIGTNIHWYQQR* – SIL Cetuximab signature peptide qualifier ASQSIGTNIHWYQQR Stable Isotope Labeled Infliximab (CTX) peptide serves as a secondary internal standard to confirm CTX’s presence in biological samples by mass spectrometry. SB-PEPTIDE’s...

YASESISGIPSR* – SIL Cetuximab signature peptide quantifier

YASESISGIPSR* – SIL Cetuximab signature peptide quantifier YASESISGIPSR Stable Isotope Labeled Infliximab (CTX) peptide serves as an internal standard to confirm CTX’s primary sequence by mass spectrometry. This allows expected sequences to be confirmed...

GLEWIGAIYPGNGDTSYNQK* – SIL Rituximab signature peptide qualifier

GLEWIGAIYPGNGDTSYNQK* – SIL Rituximab signature peptide qualifier GLEWIGAIYPGNGDTSYNQK Stable Isotope Labeled Infliximab (RTX) peptide serves as a secondary internal standard to confirm RTX’s presence in biological samples by mass spectrometry....